Synedgen, Inc.
PrivateLast Round
Grant
Oct 31, 2024
Total Funding Raised
$15.31M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Synedgen, Inc. operates in Healthcare & Life Sciences and is based in Claremont, California. Its latest recorded funding round was a Grant round in October 2024.
Synedgen, Inc. is a biotechnology company that develops glycopolymer-based therapeutics to modulate the innate immune system, reduce inflammation, and promote mucosal barrier repair.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Defense Tech
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synedgen, Inc. Comparables
Compare Synedgen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Soligenix | 78% | |
| Humanetics Corporation | 78% | |
| Insilico Medicine | 77% |
For institutional investors. Book with your work email.
Synedgen, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 31, 2024 | ||||
| Grant | Oct 15, 2024 | ||||
| Grant | Dec 10, 2020 | ||||
| Grant | Mar 3, 2020 | ||||
| Grant | Feb 18, 2020 | ||||
Private Placement | Jan 29, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Synedgen, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Australian Research Council | Grant |
| National Eye Institute (NIH) | Grant |
| Defense Health Agency | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| Joint Warfighter Medical Research Program | Grant |
| U.S. Army Medical Research Acquisition Activity | Grant |
| Congressionally Directed Medical Research Programs | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 34% MoM.
- Nov 9, 2025
Monthly visitors grew 56% MoM.
For institutional investors. Book with your work email.
Synedgen, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synedgen, Inc.'s valuation, stock price, and market status.
Is Synedgen, Inc. a public or private company?
Synedgen, Inc. is a private company.
What is the current stock price of Synedgen, Inc.?
Synedgen, Inc. is a private company, so its shares have no public market price. Caplight tracks Synedgen, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synedgen, Inc. worth (valuation)?
Valuation information for Synedgen, Inc. is not publicly available.
Can I buy Synedgen, Inc. stock?
Synedgen, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synedgen, Inc.'s last funding round?
Synedgen, Inc.'s most recent funding round was Grant on October 31, 2024.
Who are the main investors in Synedgen, Inc.?
Key investors in Synedgen, Inc. include Australian Research Council, National Eye Institute (NIH), Public Health Emergency Medical Countermeasures Enterprise, Joint Warfighter Medical Research Program, U.S. Army Medical Research Acquisition Activity.
Will Synedgen, Inc. IPO soon?
No public IPO plans have been announced for Synedgen, Inc..
How can I track Synedgen, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Synedgen, Inc.'s shares on secondary markets.